These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10434801)

  • 1. [Kinetic analysis of therapeutic doses of beta-blockers for angina pectoris based on receptor occupancy theory--relationship between beta 1-receptor occupancy or vasodilative action and dose].
    Yamada Y; Matsuyama K; Takayanagi R; Kotaki H; Sawada Y; Iga T
    Yakugaku Zasshi; 1999 Jul; 119(7):495-501. PubMed ID: 10434801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/pharmacodynamic relationship.
    Yamada Y; Ito K; Nakamura K; Sawada Y; Iga T
    Biol Pharm Bull; 1993 Dec; 16(12):1251-9. PubMed ID: 7907513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta blockers in stable angina pectoris].
    Fluri M; Meier B
    Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta receptor blockers in angina pectoris].
    Bodem G; Ochs HR
    Dtsch Med Wochenschr; 1979 Jan; 104(1):6-9. PubMed ID: 32023
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
    Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy.
    Yamada Y; Shibuya F; Hamada J; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):131-45. PubMed ID: 8719233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of beta blockers in angina pectoris.
    Ablad B; Carlsson E; Ek L; Johnsson G
    Scott Med J; 1977 Jan; 22(1):52-63. PubMed ID: 13495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.
    Lowe MD; Lynham JA; Grace AA; Kaumann AJ
    Br J Pharmacol; 2002 Jan; 135(2):451-61. PubMed ID: 11815381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta blockers in the treatment of angina pectoris].
    Hadzi Pesić Lj
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():35-8. PubMed ID: 18193808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow release beta-adrenoceptor blocking drugs.
    Harron DW; Howe A; Shanks RG
    J R Coll Physicians Lond; 1983 Apr; 17(2):126-32. PubMed ID: 6132994
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic therapy of angina pectoris.
    Zavecz JH; Bueno O
    J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable angina: maximal medical therapy is not the same as optimal medical therapy.
    Jackson G
    Int J Clin Pract; 2000; 54(6):351. PubMed ID: 11092105
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nitrates in unstable angina pectoris.
    Conti CR
    Am J Cardiol; 1987 Nov; 60(15):31H-34H. PubMed ID: 2891289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of angor].
    Pladys A
    Soins Cardiol; 1983; (4-5):25-9. PubMed ID: 6138861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.